Evolva Holding S.A.
ELVAY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.26M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.26 Million |
|---|---|
| Enterprise Value | $4.04 Million |
| Annual dividend | $124.61 |
| Earnings per Share | $0.14 |
| Beta | 0.67 |
| Outstanding Shares | 7,121,000 |
Return
| Return on Equity | -33.49% |
|---|---|
| Return on Assets | -31.90% |
| Return on Invested Capital | -29.74% |
Valuation & Multiples
| P/E Ratio | -18.13 |
|---|---|
| PEG | -23.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.56 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About EvoNext Holdings S.A.
49 employees
CEO: Gerhard Lobmaier
EvoNext Holdings SA specializes in the discovery, refinement, and distribution of cutting-edge components for the nutrition, health, and well-being industries. The enterprise was co-founded in 2004 by Alexandra Santana Sørensen, Søren V....